Companies
CytomX Therapeutics Inc (CTMX) Offers An Excellent Investment Opportunity At Current Levels
CytomX Therapeutics Inc (NASDAQ:CTMX) concluded the trading at $2.38 on Wednesday, May 14 with a fall of -4.80% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.50 and 5Y monthly beta